难治性中轴型脊柱关节炎与银屑病、外周关节受累及合并症相关:一项全国性观察研究结果
基于法国国家医保数据库的全国队列研究纳入2010至2013年新获中轴型脊柱关节炎长期疾病医保资格的22932例患者,随访至2018年12月31日,定义难治性中轴型脊柱关节炎为三种b/tsDMARD失败或两种不同作用机制b/tsDMARD失败。10798例(47.08%)接受至少一种bDMARD,其中2115例(19.59%)为难治性,多因素分析显示难治性与女性、外周关节受累、银屑病、高血压和抑郁显著相关,主要心血管事件和死亡发生率无差异。
要点
- 本队列中每5例暴露于bDMARD的患者约有1例(19.59%)符合难治性中轴型脊柱关节炎定义。
- 多因素分析显示难治性与女性、外周关节受累、银屑病、高血压和抑郁显著相关(每项p<0.001)。
- 难治性与非难治性患者的主要心血管事件(p=0.92)和死亡(p=0.87)发生率无差异。
核心结论
- 在该全国队列中,难治性中轴型脊柱关节炎影响约五分之一暴露于bDMARD的患者。
- 难治性中轴型脊柱关节炎在女性以及有外周关节受累和/或合并症的患者中更常见。
研究设计与样本
- 本研究为基于法国国家医疗行政数据库(SNDS)的全国队列研究,该数据库包含住院、长期疾病(LTI)和门诊医疗服务利用数据。
- 纳入2010至2013年间新获得强直性脊柱炎LTI资格的法国患者,随访截至2018年12月31日。
- 共纳入22932例患者,其中10798例(47.08%)接受至少一种bDMARD,无一例接受tsDMARD。
- 难治性中轴型脊柱关节炎定义为三种b/tsDMARD失败或两种不同作用机制的b/tsDMARD失败。
- 合并症和肌肉骨骼外表现采用既往描述的算法识别,采用双变量和多变量逻辑回归比较难治性与非难治性患者特征,采用竞争风险分析比较主要心血管事件和死亡发生率。
主要发现
- 随访期间2115例患者被归类为难治性中轴型脊柱关节炎,占接受至少一种bDMARD患者的19.59%。
- 多因素分析中,难治性中轴型脊柱关节炎与女性、外周关节受累、银屑病、高血压和抑郁显著相关(每项p<0.001)。
- 难治性与非难治性患者的主要心血管事件发生率无差异(p=0.92),死亡发生率也无差异(p=0.87)。
关键数值与推荐
- 难治性中轴型脊柱关节炎定义为三种b/tsDMARD失败或两种不同作用机制的b/tsDMARD失败。
- 22932例纳入患者中10798例(47.08%)接受至少一种bDMARD,无一例接受tsDMARD。
- 2115例被归类为难治性中轴型脊柱关节炎,占接受至少一种bDMARD患者的19.59%。
- 多因素分析中女性、外周关节受累、银屑病、高血压和抑郁与难治性中轴型脊柱关节炎显著相关,每项p<0.001。
- 主要心血管事件发生率的组间比较p=0.92,死亡发生率的组间比较p=0.87。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the cumulative incidence and identify the factors associated with difficult-to-treat axial spondyloarthritis (D2T-axSpA) in French patients newly benefiting from the French 'long-term illness' (LTI) social security scheme for axial spondyloarthritis (axSpA). METHODS: This national cohort study was based on the French National Medico-Administrative Database, SNDS, which contains data on hospitalisation, LTI and outpatient care consumption. All French patients newly receiving LTI benefits for ankylosing spondylitis (AS) between 2010 and 2013 were included in the study. In France, LTI is required to access biological/targeted synthetic DMARDs (b/tsDMARDs). The follow-up period ended on 31 December 2018. So-called D2T-axSpA was defined as the failure of three b/tsDMARDs or of two b/tsDMARDs with different modes of action. Comorbidities and extra-musculoskeletal manifestations were identified using previously described algorithms. Characteristics were compared between patients with D2T-axSpA and patients with non-D2T-axSpA who had received at least one b/tsDMARD with bivariate and multivariate analysis using logistic regression. Incidence rates of major cardiovascular event (MACE) and death were compared using competitive risk analysis. RESULTS: 22 932 patients were included. 10 798 (47.08%) patients received at least one bDMARD. None received tsDMARD. During follow-up, 2115 patients were classified as having D2T-axSpA, representing 19.59% of patients who received at least one bDMARD. In multivariate analysis, D2T-axSpA was significantly associated with female gender, peripheral involvement, psoriasis, hypertension and depression (p<0.001 for each case). There was no difference in the incidence of MACE (p=0.92) or death (p=0.87). CONCLUSION: D2T-axSpA affects one in five patients exposed to bDMARDs in this national cohort. D2T-axSpA is more common in women and patients with peripheral involvement and/or comorbidities.
引用
- Fakih O, Desmarets M, Martin B, et al. Difficult-to-treat axial spondyloarthritis is associated with psoriasis, peripheral involvement and comorbidities: results of an observational nationwide study. RMD Open. 2023. PMID: 37996127. doi:10.1136/rmdopen-2023-003461
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。